Therapeutic Allogeneic Lymphocytes and Aldesleukin in Treating Patients With High-Risk or Recurrent Myeloid Leukemia After Undergoing Donor Stem Cell Transplant

Name: Therapeutic Allogeneic Lymphocytes and Aldesleukin in Treating Patients With High-Risk or Recurrent Myeloid Leukemia After Undergoing Donor Stem Cell Transplant
License: Public Domain

Fred Hutchinson Cancer Center

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

accelerated phase chronic myelogenous leukemia, acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome, adult acute myeloid leukemia with 11q23 (mll) abnormalities, adult acute myeloid leukemia with del(5q), adult acute myeloid leukemia with inv(16)(p13;q22), adult acute myeloid leukemia with t(15;17)(q22;q12)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 201796
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.